menu close
clear_day clear_night Sign Up east Log In east
clear_day nightlight
search
menu close Sign Up east Log In east
Sign Up east Log In east
www.generatebiomedicines.com

Generate Biomedicines Stock

Company Profile:

Generate Biomedicines is pioneering the field of generative biology with a revolutionary approach to drug development that allows them to program protein-based modalities for the first time.

Sign up for SecondMarket™ to view the market and buy or sell Generate Biomedicines Stock
Buy + Sell

Generate Biomedicines Funding

Sign up to gain insights into Generate Biomedicines funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Jan 12, 2024 Series C 280.95M
Price
Valuation
Nov 23, 2021 Series B 373.42M
Price
Valuation
Dec 31, 2019 Series A 30.10M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

See Generate Biomedicines Valuations + Financials

Sample data + company shown for illustrative purposes only

*Sample data + company shown for illustrative purposes only

Gain insights Into Generate Biomedicines Stock Valuation + Share Prices

View real-time Tape D™ data on Generate Biomedicines stock including most recent valuation and historical share price information.

Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.

Get Started
Leverage Your Equity to Help Achieve More.

Generate Biomedicines Management Team

  • Director

    Stephane Bancel

  • Director

    Frances Arnold

  • Chief Legal Officer and General Counsel

    Sean Martin

  • CEO, Director

    Michael Nally

  • Co-Founder, Chief Technology Officer

    Gevorg Grigoryan

  • Co-Founder, Director

    Geoffrey von Maltzahn

  • Chief Financial Officer

    Jason Silvers

  • Chief People Officer

    Beth Grous

  • Director

    Jane Mendillo

  • Director

    Gary P. Pisano

  • Co-Founder, Chief Innovation Officer

    Molly Gibson

  • Director

    Noubar Afeyan

Generate Biomedicines Major Investors

  • Abu Dhabi Investment Authority (ADIA)

  • Banque Pictet

  • ARCH Venture Partners

  • T. Rowe Price Associates, Inc.

  • T. Rowe Price Associates, Inc.

  • Amgen Ventures

  • Altitude Life Science Ventures

  • Morningside Venture Investments, Ltd.

  • Morningside Venture Investments, Ltd.

  • Mirae Asset Financial Group

  • Fidelity Management & Research Company

  • NVIDIA Corporation

  • Alaska Permanent Fund (APFC)

  • March Capital

  • Flagship Pioneering

Learn More About Generate Biomedicines Stock

Buy Generate Biomedicines Stock
01
Generate Biomedicines stock does not trade on public stock exchanges. Generate Biomedicines stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Generate Biomedicines stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell Generate Biomedicines Stock
02
Generate Biomedicines Stock does not trade on public stock exchanges. In order to sell Generate Biomedicines shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
Generate Biomedicines Stock Price
03
Generate Biomedicines does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Generate Biomedicines share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Generate Biomedicines Stock Ticker Symbol
04
There is no ticker symbol for Generate Biomedicines stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Generate Biomedicines Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Generate Biomedicines stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Generate Biomedicines Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Generate Biomedicines stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Generate Biomedicines Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Generate Biomedicines IPO
08
Generate Biomedicines is a private company and has not had an IPO. There is currently no Generate Biomedicines IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Generate Biomedicines IPO.
Sign up for SecondMarket™ to view the market and buy or sell Generate Biomedicines Stock
Buy + Sell

Other Companies

Nuvocargo

Digital platform for cross-border trade between USA and Mexico.

Industry Automotive + Land Transportation About Nuvocargo Stock →

Madison Reed

Professional grade hair care products.

Industry Household Goods + Services About Madison Reed Stock →

Amount

Comprehensive end-to-end retail banking and point-of-sale solutions.

Industry Banking + Payment About Amount Stock →

Sentz

The first carbon negative cryptocurrency designed for use as digital cash on your phone, with an easy-to-use payment system and near-instantaneous transactions.

Industry Banking + Payment About Sentz Stock →

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Industry Biotechnology + Pharmaceuticals About Eikon Therapeutics Stock →

Crossover Markets

Digital asset trading technology firm focused on meeting the unique liquidity requirements of institutions in the cryptocurrency markets.

Industry Investment + Insurance About Crossover Markets Stock →
Source: Nasdaq Private Market Tape D™